ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • PRESERVING VISION AND PRODUCTIVITY: THE SOCIAL IMPACT OF INNOVATIVE DME THERAPY IN CHILE

    Mar 18, 2026, 21:38 PM
  • UTILIZATION, EXPENDITURE, AND PRICE TRENDS FOR EZETIMIBE AND NOVEL LIPID-LOWERING MEDICATIONS IN U.S. MEDICAID DRUG UTILIZATION DATA, 2002-2024

    Mar 18, 2026, 21:38 PM
  • ECONOMIC BURDEN OF DIAGNOSED METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN US ADULTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY

    Mar 18, 2026, 21:38 PM
  • A SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS AND EFFECT MODIFIERS IMPACTING TREATMENT OUTCOMES IN PRIMARY BILIARY CHOLANGITIS

    Mar 18, 2026, 21:38 PM
  • THE BUDGET IMPACT OF TUMOR-TREATING FIELDS PLUS STEREOTACTIC RADIOSURGERY AND BEST SUPPORTIVE CARE FOR TREATING 1-10 BRAIN METASTASES DUE TO NON-SMALL CELL LUNG CANCER (NSCLC)

    Mar 18, 2026, 21:38 PM
  • INCIDENT COMPLICATIONS AND TREATMENT USE IN SICKLE CELL DISEASE IN US COMMERCIAL AND MEDICARE-INSURED PATIENTS

    Mar 18, 2026, 21:38 PM
  • DEMONSTRATING THE EFFECTIVENESS OF EVIDENCE-BASED CHRONIC DISEASE SELF-MANAGEMENT EDUCATION (CDSME) PROGRAMS IN THE UNITED STATES

    Mar 18, 2026, 21:38 PM
  • COMPARATIVE ANALYSIS OF HEALTHCARE COST REDUCTION ACROSS INTENSIVE SUPPORT MODALITIES IN JAPAN’S SPECIFIC HEALTH GUIDANCE PROGRAM: USING LARGE-SCALE REAL-WORLD DATA OF EMPLOYMENT-BASED HEALTH INSURANCE CLAIMS (WELLNESS STAR DATABASE)

    Mar 18, 2026, 21:38 PM
  • EVALUATION OF AI-ASSISTED MULTI-ROW DATA EXTRACTION FOR META-ANALYSIS USING EASYSLR

    Mar 18, 2026, 21:38 PM
  • SOCIOECONOMIC BURDEN OF DRY EYE DISEASE IN THE UNITED STATES: REAL-WORLD EVIDENCE FROM THE ADELPHI DED DISEASE SPECIFIC PROGRAMME

    Mar 18, 2026, 21:38 PM
  • PREVALENCE AND SEVERITY OF ACNE VULGARIS IN FEMALE UNIVERSITY STUDENT ASSESSED FOR PCOS RISK

    Mar 18, 2026, 21:38 PM
  • U.S. REAL-WORLD PRESCRIBING PATTERNS OF MIXED GONADOTROPIN OVARIAN STIMULATION PROTOCOLS: A CLAIMS-BASED ANALYSIS

    Mar 18, 2026, 21:38 PM
  • FAST-TRACKED BUT FALLING SHORT? THERAPEUTIC VALUE AND POLICY ALIGNMENT OF FDA-APPROVED ANTIBIOTICS, 2010-2025

    Mar 18, 2026, 21:38 PM
  • APPLYING TARGET TRIAL EMULATION IN VACCINE RESEARCH: METHODOLOGICAL INSIGHTS AND REGULATORY IMPLICATIONS

    Mar 18, 2026, 21:38 PM
  • ASSOCIATION BETWEEN TELEHEALTH-DELIVERED NUTRITION THERAPY AND RISK OF NEW-ONSET OBESITY IN ADULTS WITH TYPE 2 DIABETES: A PROPENSITY SCORE-MATCHED SURVIVAL ANALYSIS

    Mar 18, 2026, 21:38 PM
  • PATIENT EXPERIENCE DOSSIERS IN PRACTICE: A DEMONSTRATION PROJECT IN METASTATIC NON-SMALL CELL LUNG CANCER

    Mar 18, 2026, 21:38 PM
  • MOST-FAVOURED NATION, LEAST-FAVOURED CONSEQUENCES: GLOBAL RIPPLE EFFECTS OF U.S. PRICING POLICY

    Mar 18, 2026, 21:38 PM
  • ECONOMIC EVALUATION OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN PRETERM INFANTS IN ECUADOR

    Mar 18, 2026, 21:38 PM
  • DISEASE BURDEN OF DIABETIC KIDNEY DISEASE IN CHINA: A SYSTEMATIC LITERATURE REVIEW

    Mar 18, 2026, 21:38 PM
  • HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST OF CARE FOR ELDERLY HF PATIENTS WHO ADD EMPAGLIFLOZIN TO TREATMENT REGIMEN

    Mar 18, 2026, 21:38 PM
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group